Guggenheim Maintains Buy on Acadia Healthcare Co, Raises Price Target to $38

Benzinga Newsdesk www.benzinga.com Positive 83.4%

Neg 0% Neu 0% Pos 83.4%

Guggenheim analyst Jason Cassorla maintains Acadia Healthcare Co (NASDAQ:ACHC) with a Buy and raises the price target from $31 to $38.